Credit:
Lawrence Livermore National Laboratory has joined with partners at other national labs, industry, and academia in the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, aimed at creating a new paradigm of cancer drug discovery that would reduce the time from an identified drug target to clinical candidate from six years to just 12 months.